Viewing StudyNCT00061945



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00061945
Status: COMPLETED
Last Update Posted: 2022-05-03
First Post: 2003-06-05

Brief Title: Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Sponsor:
Organization: National Cancer Institute NCI